DermTech Pledges up to $1 Million to Raise Awareness and Support Accessibility of Skin Exams

Business Wire


LA JOLLA, Calif.--(BUSINESS WIRE)--In honor of Melanoma and Skin Cancer Awareness Month, DermTech, Inc. (NASDAQ: DMTK) (“DermTech”), a leader in precision dermatology enabled by the non-invasive DermTech Smart Sticker™ platform and its melanoma test, the Pigmented Lesion Assay or PLA, is launching the #Stickit2Melanoma campaign, urging the public to get proactive about skin exams. One in five Americans develop skin cancer by the age of 70, and every hour of every day one American dies from mela

Full Article